Role of the androgen receptor in urothelial cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2017-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mce.2017.06.021PMID 28652170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies

  2017cited by this paper
• Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract

  2017cited by this paper
• Cancer statistics, 2017

  2017cited by this paper
• Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression.

  2017cited by this paper
• High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer

  2017cited by this paper
• Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta‐Analysis of 13,140 Patients

  2017cited by this paper
• GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.

  2017cited by this paper
• Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5&agr;‐Reductase Inhibitor

  2017cited by this paper
• Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer

  2016cited by this paper
• Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.

  2016cited by this paper
• Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract

  2016cited by this paper
• Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice

  2016cited by this paper
• Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.

  2016cited by this paper
• GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.

  2016cited by this paper
• Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence

  2016cited by this paper
• Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals

  2016cited by this paper
• Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors.

  2016cited by this paper
• Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting

  2016cited by this paper
• Effect of orchiectomy and testosterone replacement on lower urinary tract function in anesthetized rats.

  2016cited by this paper
• Androgen receptor (AR) promotes male bladder cancer cell proliferation and migration via regulating CD24 and VEGF.

  2016cited by this paper
• Emerging therapeutic targets in bladder cancer.

  2015cited by this paper
• Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals

  2015cited by this paper
• Deaths Due to Cigarette Smoking for 12 Smoking-Related Cancers in the United States.

  2015cited by this paper
• Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation.

  2015cited by this paper
• Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.

  2015cited by this paper
• Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.

  2015cited by this paper
• Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression

  2015cited by this paper
• Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals

  2015cited by this paper
• The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.

  2015cited by this paper
• Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy

  2015cited by this paper
• Expression of UDP‐glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen

  2014cited by this paper
• Role of steroid hormone receptors in formation and progression of bladder carcinoma: a case-control study.

  2014cited by this paper
• Androgen deprivation therapy prevents bladder cancer recurrence

  2014cited by this paper
• Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

  2014cited by this paper
• Prognostic Value of Sex-Hormone Receptor Expression in Non-Muscle-Invasive Bladder Cancer

  2014cited by this paper
• Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer

  2014cited by this paper
• The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage

  2014cited by this paper
• Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition.

  2014cited by this paper
• GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens.

  2014cited by this paper
• Androgen receptor inducing bladder cancer progression by promoting an epithelial–mesenchymal transition

  2014cited by this paper
• Evaluation of contemporary prostate and urothelial lineage biomarkers in a consecutive cohort of poorly differentiated bladder neck carcinomas.

  2014cited by this paper
• Androgen receptor immunohistochemistry in genitourinary neoplasms

  2014cited by this paper
• The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells

  2013cited by this paper
• Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.

  2013cited by this paper
• Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity

  2013cited by this paper
• Nur77 Inhibits Androgen-Induced Bladder Cancer Growth

  2013cited by this paper
• Somatic mutation of the androgen receptor gene is not associated with transitional cell carcinoma: a "negative" study by whole-exome sequencing analysis.

  2013cited by this paper
• Androgen receptor signals regulate UDP‐glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen‐induced bladder carcinogenesis

  2013cited by this paper
• Androgen activates β-catenin signaling in bladder cancer cells.

  2013cited by this paper
• Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.

  2013cited by this paper
• Mini-review: Foldosome regulation of androgen receptor action in prostate cancer

  2013cited by this paper
• Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium.

  2013cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer.

  2012cited by this paper
• Androgen deprivation induces bladder histological abnormalities and dysfunction via TGF-β in orchiectomized mature rats.

  2012cited by this paper
• CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated

  2012cited by this paper
• Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder

  2012cited by this paper
• Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor

  2012cited by this paper
• GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.

  2012cited by this paper
• Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Prognostic effects and regulation of activin A, maspin, and the androgen receptor in upper urinary tract urothelial carcinoma.

  2011cited by this paper
• Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer

  2011cited by this paper
• Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional study

  2011cited by this paper
• Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression.

  2011cited by this paper
• Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005

  2011cited by this paper
• Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.

  2011cited by this paper
• CAG repeats in the androgen receptor gene are shorter in patients with pulmonary, esophageal or bladder carcinoma and longer in women with uterine leiomyoma.

  2010cited by this paper
• Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer.

  2010cited by this paper
• Androgen receptor is a potential therapeutic target for bladder cancer.

  2010cited by this paper
• Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract

  2009cited by this paper
• The effect of smoking on the male excess of bladder cancer: A meta‐analysis and geographical analyses

  2009cited by this paper
• Economic aspects of bladder cancer: what are the benefits and costs?

  2009cited by this paper
• Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

  2009cited by this paper
• Somatic mutations of adenomatous polyposis coli gene and nuclear b‐catenin accumulation have prognostic significance in invasive urothelial carcinomas: Evidence for Wnt pathway implication

  2009cited by this paper
• Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.

  2008cited by this paper
• Temporal-spatial protein expression in bladder tissue derived from embryonic stem cells.

  2008cited by this paper
• Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1

  2008cited by this paper
• Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma.

  2008cited by this paper
• Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.

  2008cited by this paper
• Androgen deprivation therapy for prostate cancer

  2008cited by this paper
• Lower urinary-tract symptoms and testosterone in elderly men

  2008cited by this paper
• Effect of castration on male rabbit lower urinary tract tissue enzymes

  2007cited by this paper
• Promotion of bladder cancer development and progression by androgen receptor signals.

  2007cited by this paper
• ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor

  2007cited by this paper
• Characterization and functional role of androgen-dependent PDE5 activity in the bladder.

  2007cited by this paper
• Behavior of urothelial carcinoma with respect to anatomical location.

  2007cited by this paper
• Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

  2004cited by this paper
• The androgen receptor revisited in urothelial carcinoma

  2004cited by this paper
• Allelic loss of the active X chromosome during bladder carcinogenesis.

  2004cited by this paper
• Androgen receptor in prostate cancer.

  2004cited by this paper
• Androgen Receptor Coregulators in Prostate Cancer

  2004cited by this paper
• Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces.

  2004cited by this paper
• Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.

  2003cited by this paper
• The sex hormone receptors in the bladder in childhood - I: preliminary report in male subjects.

  2002cited by this paper
• Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues

  2002cited by this paper
• Effects of testosterone on neuromuscular transmission in rat isolated urinary bladder.

  2002cited by this paper

• Recent advances in understanding the role of sex hormone receptors in urothelial cancer

  2025influential citation
• Concurrent occurrence of adenocarcinoma and urothelial carcinoma of the prostate: Coexistence mechanisms from multiple perspectives

  2025cites this paper
• Investigation of androgen receptor expression in urothelial carcinoma of the bladder

  2025cites this paper
• Latrophilin-1 and latrophilin-2 as androgen receptor-responsive G protein-coupled receptors promote bladder cancer progression.

  2025cites this paper
• Mineralocorticoid receptor signaling inhibits bladder cancer progression.

  2024cites this paper
• Latrophilin-3 as a downstream effector of the androgen receptor induces bladder cancer progression

  2024cites this paper
• GULP1 as a Downstream Effector of the Estrogen Receptor-β Modulates Cisplatin Sensitivity in Bladder Cancer

  2024cites this paper
• Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma

  2024cites this paper
• Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK/JUP signalling

  2023cites this paper
• Role of the Androgen Receptor in Gender-Related Cancers

  2023cites this paper
• Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer.

  2023cites this paper
• GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer

  2023cites this paper
• 5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data

  2023cites this paper
• Protective role of mineralocorticoid receptor signaling in urothelial tumorigenesis.

  2023cites this paper
• Androgen receptor modulation and bladder cancer prevention - a short review.

  2022cites this paper
• In Utero Exposure to 3,3′,4,4′, 5-Pentachlorobiphenyl Dose-Dependently Induces N-butyl-4-(hydroxybutyl) Nitrosamine in Rats With Urinary Bladder Carcinoma

  2022cites this paper
• Differences in SUV39H1 and androgen receptor distribution in adenomyomatous hyperplasia and prostatic adenocarcinoma

  2022cites this paper
• Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing

  2021cites this paper
• Androgen Receptor Regulates CD44 Expression in Bladder Cancer

  2021cites this paper
• The Role of Estrogen Receptors in Urothelial Cancer

  2021cites this paper
• Oxidative Stress in Genitourinary Cancer

  2021cites this paper
• High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer

  2021cites this paper
• FOXO1 inactivation induces cisplatin resistance in bladder cancer

  2020cites this paper
• OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

  2020cites this paper
• Evaluation of androgen receptor status in urothelial carcinoma of the urinary bladder in Egyptian patients: an immunohistochemical study

  2020cites this paper
• A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)

  2020cites this paper
• High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer

  2020cites this paper
• The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma

  2020cites this paper
• Compound A inhibits urothelial tumorigenesis via both the androgen receptor and glucocorticoid receptor signaling pathways.

  2020cites this paper
• Effects of α1-adrenergic receptor antagonists on the development and progression of urothelial cancer.

  2020cites this paper
• Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.

  2019cites this paper
• Dihydrotestosterone increases the risk of bladder cancer in men

  2019cites this paper
• Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder Cancer.

  2019cites this paper
• Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder.

  2019cites this paper
• The Catechol-Methyltransferase rs4680 G > A Polymorphism is Associated with Uterine Leiomyoma Susceptibility

  2019cites this paper
• Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer

  2019cites this paper
• The Role of Mineralocorticoid Receptor Signaling in Genitourinary Cancers

  2019cites this paper
• Clinicopathological and prognostic significance of androgen receptor overexpression in colorectal cancer

  2019cites this paper
• High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer

  2018cites this paper
• Cancer risk by the subtype of alopecia

  2018cites this paper
• Bioinformatic analysis of gene expression profile in prostate epithelial cells exposed to low-dose cadmium

  2018cites this paper
• Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling

  2018cites this paper
• Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract

  2018cites this paper
• Androgens and androgen receptor: Above and beyond.

  2018cites this paper
• Uridine 5'diphospho‐glucuronosyltransferase 1A expression as an independent prognosticator in urothelial carcinoma of the upper urinary tract

  2018cites this paper
• Editorial Comment

  2018cites this paper
• Forkhead box O 1 as an indicator of prognosis is inactivated in urothelial carcinoma of the upper urinary tract

  2018cites this paper
• Forkhead box O1 as an indicator of prognosis is inactivated in urothelial carcinoma of the upper urinary tract.

  2018cites this paper
• ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor.

  2018cites this paper
• ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling

  2018cites this paper
• Distribution of androgen receptor expression in the urinary bladder

  2018cites this paper
• Adult Urology Oncology: Adrenal/Renal/Upper Tract/Bladder Finasteride Use and Risk of Bladder Cancer in a Multiethnic Population

  year unknowninfluential citation